Validating Orchid’s Breast Cancer Genetic Risk Score
Written by Orchid Bioinformatics Staff
Orchid's clinical reports include a genetic risk score (GRS) for breast cancer, which has been validated on data from the UK Biobank. We present our findings from this validation study in the following white paper. We found that the GRS performed well, particularly for identifying individuals with elevated risk of the disease relative to the population. The breast cancer GRS is available to individuals of all ancestry groups.
.svg){kind=small}
